Study of the Effects of Intravenous Exenatide on Cardiac Repolarization

NCT02650479 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Male and Female Volunteers

Interventions

DRUG: Exenatide
DRUG: Placebo
DRUG: Moxifloxacin
DRUG: Palonosetron

Sponsor

Intarcia Therapeutics